Lloyd Mitchell Segal - 12 Mar 2025 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Steve Forte, Attorney-in-Fact
Issuer symbol
RPTX
Transactions as of
12 Mar 2025
Net transactions value
-$24,144
Form type
4
Filing time
14 Mar 2025, 16:30:13 UTC
Previous filing
06 Mar 2025
Next filing
08 Jan 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPTX Common Shares Sale $24,144 -21,179 -15% $1.14 124,394 12 Mar 2025 Direct F1
holding RPTX Common Shares 107,558 12 Mar 2025 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represent shares sold to satisfy the Reporting Person's tax withholding obligation in connection with the vesting and settlement of restricted stock units and does not represent a discretionary sale by the holder.
F2 These securities are registered in the name of Arvala Inc. (f/k/a 3996953 Canada Inc., the "Company"). The Reporting Person is the sole stockholder of the Company.